A risk assessment tool (OsteoRisk) for identifying latin American women with osteoporosis
Cite this article as: Sen, S.S., Rives, V.P., Messina, O.D. et al. J GEN INTERN MED (2005) 20: 245. doi:10.1111/j.1525-1497.2005.40900.x Abstract To develop a simple and easy-to-use tool for identifying osteoporotic women (femoral neck bone mineral density [BMD] T-scores ≤−2.5) in Latin America. OBJECTIVE: Retrospective study involving review of medical records. DESIGN: Osteoporosis clinics in 6 Latin American countries. SETTING: Postmenopausal women ages ≥50 in Latin America who had femoral neck BMD measurements. PATIENTS: A risk index was developed from 1.547 patients based on least square regression using age, weight, history of fractures, and other variables as predictors for BMD T-score. The final model was simplified by reducing the number of predictors; sensitivity and specificity were evaluated before and after reducing the number of predictors to assess performance of the index. The final model included age, weight, country, estrogen use, and history of fractures as significant predictors for T-score. The resulting scoring index achieved 91% sensitivity and 47% specificity. Simplifying the index by using only age and weight yielded similar performance (sensitivity, 92%; specificity, 45%). Three risk categories were identified based on OsteoRisk, the index using only age and body weight: high-risk patients (index <=−2; 65.6% were osteoporotic), moderate-risk patients (−2<index <=1; 26.7% were osteoporotic), and low-risk patients (index>1; 8% were osteoporotic). Similar results were seen in a validation sample of 279 women in Brazil. MEASUREMENTS AND MAIN RESULTS: Age and weight alone performed well for predicting the risk of osteoporosis among postmenopausal women. The OsteoRisk is an easy-to-use tool that effectively targets the vast majority of osteoporotic patients in Latin America for evaluation with BMD. CONCLUSION: Key words osteoporosis bone mineral density risk assessment
Dr. Shuvayu S. Sen and Dr. Phillip D. Ross are employees of Merck & Company, Inc.
The results were presented in part at the Fourth Conference on the Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Nice, France, November 2003.
This study was funded in part by Merck & Company, Inc. The authors would like to acknowledge Dr. Olga Geling for her support with data analysis.
Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA
. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am. 2000;82:A:1063–70.
. Questionnaire survey of advice given to patients with fractures. BMJ. 1999;318:500–1.
Schnitzer TJ, Wehren LE. The patient with a fragility fracture: an evolving role for the orthopaedic surgeon. O J Med. 2004;97:101–4.
Murrillo-Uribe A, Deleze-Hinojosa M, Aguirre E, et al. [Osteoporosis in Mexican postmenopausal women. Magnitude of the problem. Multicenter study.] Cinecol Obstet Mex. 1999;67:227–33.
Lams HG. [Situation of osteoporosis in Chile.] Rev Med Chil. 2000;128:809–12.
Arrigada M, Arinoviche R, Rodriguez JA. The prevalence of osteopoina and osteoporosis in Chile. Galenus. 1987;9:33–6.
Revista Veja. Edicion 1658/Julio 2000, Brazil.
Riera G. Realidad de la osteoporosis en Venezula. Rev Informe Medico. 2003;3:354–56.
Bacon WE, Maggi S, Looker A, et al.
International comparison of hip fracture rates in 1988–89. Osteoporos Int. 1996;6:69–75.
Castro Da Rocha FA, Ribeiro AR
. Low incidence of hip fractures in an equatorial are. Osteoporos Int. 2003;14:496–99.
Clark P, de la Pena F, Gomez Garcia F, Orozco JA, Tugwell P
. Risk factors for osteoporotic hip fractures in Mexicans. Arch Med Res. 1998;29:253–7.
Barros ER, Kasamatsu TS, Ramalho AC, Hauache OM, Vieira JG, Lazaretti-Castro M
. Bone mineral density in young women of the city of Sao Paulo, Brazil: correlation with both collagen type I alpha 1 gene polymorphism and clinical aspects. Braz J Med Biol Res. 2002;35:885–93.
Cooper C, Campion G, Melton LJ III
. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9.
Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston CC Jr
. Predictors of bone mass in perimenopausal women. Ann Intern Med. 1990;112:96–100.
Ribot C, Pouilles JM, Bonneau M, Tremollieres F. Assessment of the risk of post-menopausal osteoporosis using clinical factors. Clin Endocrinol. 1992;36:225–8.
Bauer DC, Browner WS, Cauley JA, et al.
Factors associated with appendicular bone mass in older women. Ann Intern Med. 1993;118:657–65.
Lydick E, Cook K, Turpin J, et al.
Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone mass. Am J Manag Care. 1998;4:37–48.
Koh LK, Sedrine WB, Torralba TP, et al.
Osteoporosis Self-assessment Tool for Asians (OSTA) Research Group. A simple tool to identify Asian women at increased risk of osteoporsis. Osteoporos Int. 2001;12:699–705.
Fujiwara S, Masunari N, Suzuki G, Ross PD
. Performance of osteoporosis risk indices in a Japanese population. Curr Ther Res. 2001;62:586–94.
Geusens P, Hochberg MC, van der Voort DJ, et al.
Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc. 2002;77:629–37.
Cadarette SM, McIsaac WM, Hawker GA, et al.
The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing. Osteoporos Int. 2004;15:361–6.
Ross PD, Wasnich RD, Davis JW
. Fracture prediction models for osteoporosis prevention. Bone. 1990;11:327–31.
Mautalen C, Pumarino H
. Epidemiology of osteoporosis in South America. Osteoporos Int. 1997;7(suppl 3):S73-S77.
Sapunar J, Bravo P, Schneider H, Jimenez M
. [Is Mapuche ethnicity a risk factor for hip fracture in aged?] Rev Med Chil. 2003;131:1135–41.
Garcia-Ramos G, Gellez-Zenteno JF, Zapata-Zuniga M, et al.
HLA class II genotypes in Mexican Mestizo patients with myashthenia gravis. Eur J Neurol. 2003;10:707–10.
Ramalho AC, Lazaretti-Castro M, Hauache O, et al.
Osteoporotic fractures of proximal femur: clinical and epidemiological features in a population of the city of Sao Paulo. Sao Paulo Med J. 2001;119:48–53.
Carranza-Lira S, Rosas M, Murillo A, Martinez N, Santos J
. Osteoporosis in postmenopausal women (Mexico City): 1. Risk factors. Int J Fertil Womens Med. 2002;47:22–5.
Martorell R, Khan LK, Hughes ML, Grummer-Strawn LM
. Obesity in Latin American women and children. J Nutr. 1998;128:1464–73.
WHO Study Group. Assessment of fracture risk and its application to screening for post menopausal osteoporosis. WHO technical report series 843. Geneva, Switzerland: WHO; 1994.
Mallows C. Some comments on Cp. Technometrics. 1973;661–76.
Rawlings JO. Applied Regression Analysis. Pacific Grove, CA: Wadsworth & Brooks/Cole; 1988.
. Relationships among body mass, its components, and bone. Bone. 2002;31:547–55.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1992;143:29–36.
Carranza-Lira S, Rosas M, Murillo A, Martinez N, Santos J
. Osteoporosis in postmenopausal women (Mexico City): 2. Validation of a predictive clinical index. Int J Fertil Womens Med. 2002;47:26–31.
Richy F, Gourlay M, Ross PD, et al.
Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium. QJM. 2004;97:39–46.
Hawker GA, Jamal SA, Ridout R, Chase C
. A clinical prediction rule to identify premenopausal women with low bone mass. Osteoporos Int. 2002;13:400–6.
Sen SS, Geling O, Messina OD, et al. Comparison of body weight and body mass index as predictors for osteoporosis among postmenopausal Latin American women. Osteoporos Int. 2002;(suppl 3):S27.
Goemaere S, Segels B, Toye K, et al.
Limited clinical utility of a self-evaluating risk assessment scale for postmenopausal osteoporosis: lack of predictive value of lifestyle-related factors. Calcif Tissue Int. 1999;65:354–8.
Bohannon AD, Hanlon JT, Landerman R, Gold DT
. Association of race and other potential risk factors with nonvertebral fractures in community-dwelling elderly women. Am J Epidemiol. 1999;149:1002–9.
Kung AW, Ho AY, Sedrine WB, Reginster JY, Ross PD
. Comparison of a simple clinical risk index and quantitative bone ultrasound for identifying women at increased risk of osteoporosis. Osteoporos Int. 2003;14:716–21.
Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV
. Development and validation of the Osteoporosis Risk Assessment Instrument to facillitate selection of women for bone densitometry. CMAJ. 2000;162:1289–94.
Sedrine WB, Chevallier T, Zegels B, et al.
Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry. Gynecol Endocrinol. 2002;16:245–50.
PubMed CrossRef Copyright information
© Society of General Internal Medicine 2005